Skip to main content
NIH funding notice PAR-22-117

Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional)

Closed on March 31, 2022.

Posted
February 14, 2022
Close date
March 31, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $538,840 in first-year total cost, median $269,420.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IFCN-T (90)]2

Most frequent institutions

  1. UNIVERSITY OF CALIFORNIA LOS ANGELES1
  2. UNIVERSITY OF ILLINOIS AT CHICAGO1
Competing awards under PAR-22-117 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022VRC: Engineered extracellular vesicles for mild TBI-induced retinal injury1R01EY034716-01ROTH, STEVENUNIVERSITY OF ILLINOIS AT CHICAGO, IL$337,600ZRG1
2022VRC: Reduction of Vision Loss with Early Interventions After Optic Nerve Injury1R01EY034715-01BRECHA, NICHOLAS C.UNIVERSITY OF CALIFORNIA LOS ANGELES, CA$201,240ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.